Blog Posts Archives

SECOND OPINION: Don’t Be Fooled. Drug Companies Are Responsible For High Drug Prices

Oct 23, 2018

Repeating the same false claim over and over again doesn’t make it true. … Read More

Second Opinion: The Truth About The Big Pharma Bailout

Sep 25, 2018

In their latest attempt to make billions of dollars on the backs of patients,… Read More

Stop Big Pharma’s $4 Billion Bailout

Sep 21, 2018

As the country is hoping for lower drug prices, more affordable care… Read More

SECOND OPINION: Big Pharma Continues Pointing Fingers for Excessive Drug Prices

Sep 12, 2018

Apparently, when it comes to out-of-control drug prices, everyone’s to blame… Read More

Second Opinion: The Real Source of Rising Drug Prices

Sep 10, 2018

Big Pharma is always eager to play the blame game – attempting to divert… Read More

Campaign Launches Nationwide Effort to Highlight Voter Concerns Over Rising Prescription Drug Prices

Jul 11, 2016

“Voters across the country are calling for action by their elected officials to make sure patients and families don’t have to choose between filling a prescription and putting food on the table,” said CSRxP Executive Director John Rother. “The trend of rising drug prices needs to be addressed, and we expect voters will take that message – and a call for solutions – to candidates at all levels this fall.” Read More

Rising Prescription Drug Prices: Can We Keep Up?

May 19, 2016

We need to move toward market-based solutions to increase transparency, promote competition, and enhance value. For the millions of Americans living with chronic conditions - including allergies and arthritis, these solutions cannot come soon enough. Read More

Real People. Unconscionable Numbers.

May 5, 2016

Troubling numbers from the Centers for Disease Control and Prevention (CDC) this week show nearly 3.5 million Americans are currently living with hepatitis C – many of which are unaware of their infection. Luckily, this chronic illness is treatable, but at a staggering cost. Read More

CSRxP Introduces Proposals for Change

Apr 27, 2016

The Campaign for Sustainable Rx Pricing (CSRxP) kicked off the week with the introduction of its new policy platform aimed to curb skyrocketing prescription drug prices through increased transparency and competition which results in value. CSRxP’s solutions come at a critical time in the conversation about drug pricing, as this bipartisan issue garners unprecedented attention among policymakers, voters, and presidential candidates. Read More

One Thing Presidential Candidates Can Agree On

Mar 1, 2016

Seven presidential candidates are still in the race heading into Super Tuesday and all of them are talking about rising prescription drug prices. While they differ in their solutions to this epidemic, candidates on both sides of the aisle agree that drug prices are rising at an unsustainable rate. Read More

Real People. Real Stories.

Feb 16, 2016

Crippling drug prices have quickly become one of the hottest topics in health care. Consumers, patients, state budgets and public programs are feeling the burden, and reports show that we’re just getting started. Read More

What They Are Saying: Candidates Talk Rx Pricing on the Campaign Trail

Jan 20, 2016

Skyrocketing drug prices have been a hot issue on the presidential campaign trail. Candidates on both sides of the aisle are talking about the harmful impact these price tags have on Americans, and voters nationwide have been helping drive the conversation. Read More